Additionally, the point of fatty acid attachment differs: retatrutide uses Lys30, whereas tirzepatide is acylated at Lys20
For more information and details about eligibility and restrictions, visit or
J Surg Res 2013;185:825-32.ArticlePubMed 13
Common eligibility criteria may include: BMI of 30 or higher BMI of 27 or higher with at least one weight-related health condition History of failed diet attempts or weight regain Appetite, cravings, or portion control challenges Metabolic risk factors such as insulin resistance, elevated glucose, high cholesterol, or hypertension Need for physician-supervised weight loss due to medical complexity Eligibility must be determined through a medical consultation
The GLP-1 fatigue management guide covers strategies in depth
That said, many of the more affordable options from Hers involve compounded GLP-1s, which arent FDA-approved